[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ipharmacenter ipharmacenter
ipharmacenter posts on X about eli lilly, $abbv, breakingnews, kite the most. They currently have XXX followers and XXX posts still getting attention that total X engagements in the last XX hours.
Engagements: X #
- X Week XXX -XX%
- X Month XXXXX +69%
- X Months XXXXX -XXXX%
- X Year XXXXX +87%
Mentions: X #
- X Week XX -XXXX%
- X Month XX +187%
- X Months XX +85%
- X Year XX +50%
Followers: XXX #
- X Week XXX -XXXX%
- X Month XXX +0.78%
- X Months XXX -XXXX%
- X Year XXX no change
CreatorRank: undefined #
Social Influence
Social category influence stocks
Social topic influence eli lilly #224, $abbv #75, breakingnews, kite, $pharma, $696b, #kite, $47b
Top accounts mentioned or mentioned by @novartis
Top assets mentioned Eli Lilly and Company (LLY) AbbVie Inc (ABBV)
Top Social Posts
Top posts by engagements in the last XX hours
"Giants like J&J #Pfizer and #Merck still lead but watch for #revenue surges from #EliLilly and #NovoNordisk driven by #GLP1 innovation. #Pharma #Biotech #Healthcare #PharmaNews #IndustryTrends #Innovation #Biopharma #BigPharma #Trump #CTAD25 #CTAD2025"
X Link 2025-12-03T07:43Z XXX followers, XX engagements
"Top XX $Pharma by Revenues 2025 unveils J&J leading with $69.6B YTD followed by #Roche #AbbVie #Pfizer & #EliLilly. Oncology immunology & diabetes therapies drive growth worldwide. #Pharma #Biopharma #Oncology #Immunology #Diabetes #Weightloss"
X Link 2025-12-03T14:35Z XXX followers, XX engagements
"#EliLilly cuts prices on #Zepbound single-dose vials to expand obesity drug access in the #US as #GLP1 market intensifies #news #media #pharma #pharmaceutical #globalhealth #Zepbound #Obesity #GLP1 #EliLilly #DrugPricing"
X Link 2025-12-03T19:52Z XXX followers, XX engagements
"The US #FDA approves a new regimen for relapsed or refractory #FollicularLymphoma: Epkinly + R2. A significant move in #Oncology #AbbVie #Lymphoma #CancerTreatment #RegulatoryApproval #OncoAlert #ESMOASIA25 #ESMO25 #pharma #pharmaceutical #Media"
X Link 2025-12-05T08:57Z XXX followers, XX engagements
"The US #FDA approves a new regimen for relapsed or refractory #FollicularLymphoma: #Epkinly + R2. A significant move in #Oncology #AbbVie #Lymphoma #CancerTreatment #RegulatoryApproval #OncoAlert #ESMOASIA25 #ESMO25 #pharma #pharmaceutical #Media #cancer"
X Link 2025-12-05T10:58Z XXX followers, XX engagements
"#Kite showcases nextgeneration bicistronic CAR Tcell therapies KITE753 and KITE363 in R/R LBCL at #ASH25 #ASH2025 #news #media #pharma #breakingnews #oncology #OncoAlert #OncoTwitter #cancercure #Gilead #immunooncology #immunotherapies #Oncology"
X Link 2025-12-07T14:54Z XXX followers, XXX engagements
"#Kite Unveils Promising Phase X Results for Bicistronic CAR T-Cell Therapies in B-Cell #Lymphoma #pharma #pharmaceutical #ASH25 #ASH2025 #hematology #cancer #OncoTwitter #OncoAlert #news #media #bloodcancer #ESMODailyReporter #ESMOAsia25 #breakingnews"
X Link 2025-12-07T16:17Z XXX followers, XX engagements
"#NovoNordisk acquires #AkeroTherapeutics for $4.7B adding first-in-class FGF21 analogue to its MASH #pipeline amid #obesity boom. Full analysis: #NovoNordisk #MASH #Obesity #PharmaDeals #Biotech #MedTwitter #news #media #weightloss #diabetes"
X Link 2025-12-08T15:45Z XXX followers, XX engagements
"#FDA clears J&Js #Simponi (golimumab) as first monthly maintenance for pediatric UC (ages 2+ 15kg) after Phase X success. Reduces injection burden for kids. Details: #FDA #Simponi #PediatricUC #JNJ #IBD #Pharma #MedTwitter #Gastroenterology #news"
X Link 2025-12-08T16:47Z XXX followers, XX engagements